Psychemedics Profit Margin 2010-2024 | PMD

Current and historical gross margin, operating margin and net profit margin for Psychemedics (PMD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Psychemedics net profit margin as of December 31, 2024 is -9.26%.
Psychemedics Annual Profit Margins
Psychemedics Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.020B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.257B 18.98
Encompass Health (EHC) United States $11.907B 25.24
DaVita (DVA) United States $10.857B 15.27
Elanco Animal Health (ELAN) United States $7.326B 15.69
Chemed (CHE) United States $6.816B 21.42
Option Care Health (OPCH) United States $5.052B 22.52
RadNet (RDNT) United States $4.151B 263.43
Amedisys (AMED) United States $3.205B 21.56
Addus HomeCare (ADUS) United States $2.062B 22.64
LifeStance Health (LFST) United States $1.839B 0.00
Astrana Health (ASTH) United States $1.372B 33.99
U.S Physical Therapy (USPH) United States $1.166B 30.10
Pennant (PNTG) United States $0.891B 32.71
Aveanna Healthcare Holdings (AVAH) United States $0.835B 47.56
Atai Life Sciences (ATAI) Germany $0.527B 0.00
Daxor (DXR) United States $0.045B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.039B 0.00
Ontrak (OTRK) United States $0.002B 0.00